i'd say that the sPP dilution of extra shares have been consumed, and i'd say now its time for the sahre price to move forward, i'd say here is the third triangle formation forming
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%